Status:
UNKNOWN
Quality of Life and High-Risk Abdominal Cancer Surgery
Lead Sponsor:
University Hospital, Geneva
Conditions:
Quality of Life
Surgery
Eligibility:
All Genders
18+ years
Brief Summary
The investigators plan to measure the changes of health-related quality of life (HRQoL) at 6 months and 12 months after the following high-risk oncological abdominal surgery: gastrectomy, esophagectom...
Eligibility Criteria
Inclusion
- \- Adult patients (\>18 years) scheduled for the following elective abdominal cancer surgery known for high one-year mortality4: gastrectomy; esophagectomy; pancreas resection and hepatectomy
Exclusion
- Patients with inoperable tumours; i.e. some patients will be excluded at the time of surgery if unexpected advanced tumour staging is confirmed intraoperatively (e.g. peritoneal carcinomatosis or any other diagnosis without therapy).
- Hepatectomy for metastasectomy
- Mentally impaired patients (known diagnosis)
- Psychotic diagnoses (i.e. schizophrenia)
- Dementia (mini mental score (MMSE) \< 18)
- Incapacity to understand the information sheet
- Blindness (unable to perform the visual part of the mini-mental state examination)
Key Trial Info
Start Date :
September 5 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2024
Estimated Enrollment :
295 Patients enrolled
Trial Details
Trial ID
NCT04444544
Start Date
September 5 2020
End Date
December 30 2024
Last Update
March 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospitals of Geneva
Geneva, Switzerland, 1206